IDEX Biometrics (IDEX)

[strongbuy]

plukket mer i idex i går og dag så er ganske smekkfull så får dessverre ikke kjøpt mer

[Petersen2]

Idex ville være volatil hele tiden, det vi ser noe er at endel emisjonsaksjer går ut pluss at det er noe shorting. En close over 3 er sterkt og noe vi bør søke å få til da det vil vise en styrke. Det er uansett bare spørsmål om tid før det komme noen nyheter som drar oss over 3.2 og da starter det morsomme.

Man skal ikke frykte slike nedganger men heller kjøpe dippene. Idex har en pen stigende kanal og vil trolig fortsette oppover. Jeg tror flere og flere ser størrelsen på markedet og at Idex vil ta markdedsandeler. Jeg forventer en kurs på rundt 5 til påske

[strongbuy]

Aksjeanalyser.com har i dag sett nærmere igjen på en av sine aller største...

[dolvik]

Er det noe info om når de skal noteres på nasdaq?

[rayman]

Det der er type det, regner med han sitter fullastet selv…

[Petersen2]

Jeg antar at nå innfrir selskapet alle krav for IPO og notering Nasdaq etter gjennomført emisjon. Kan ta alt fra en uke til en måned om jeg skulle tippe.

[strongbuy]

Crypto currency Mastercard to accept cryptocurrency payments by end of 2021
Mastercard to accept cryptocurrency payments by end of 2021
Florian Bayard
BY FLORIAN BAYARD
02/11/2021
0 COM
Mastercard is about to accept cryptocurrency payments. After Visa and PayPal, the bank card issuer will support certain cryptocurrencies directly on its network by the end of the year. Initially, Mastercard will limit itself to stablecoins, these digital currencies whose price is stable. Bitcoin, Ethereum or even XRP are therefore not concerned.

mastercard accepts cryptocurrency payments

In a post on its official blog, Mastercard announces that preparations are underway for the "future of cryptocurrency and payments . " The New York-based company “will begin supporting certain cryptocurrencies directly on our network this year”. Concretely, MasterCard will allow its nearly one billion users to spend cryptocurrency with more than 30 million merchants around the world. Not surprisingly, Mastercard membership will help accelerate the adoption of cryptocurrencies among the general public.

To justify Mastercard’s decision, Raj Dhamodharan, executive vice president of the American group, explains: “We notice that users are increasingly taking advantage of crypto cards to access these assets and convert them into traditional currencies to spend them” . Many cryptocurrency exchange platforms indeed offer bank cards for spending Bitcoins or altcoins. This is particularly the case with the Binance trading platform, the essential Coinbase or Crypto.com. These cards automatically convert digital currencies into fiat currencies(euro, dollar,…) during a payment. Ultimately, the merchant receives fiat currencies and not cryptocurrencies. With the announcement of Mastercard, the situation will change: cryptocurrency transfers will be possible

[fishstick]

God omsetning i dag - og kursen går

[strongbuy]

IDEX: FORVENTER ADS-HANDELSSTART PÅ NASDAQ 24. FEBRUAR

Oslo (TDN Direkt): Idex har søkt om å notere ADSer (American Depositary Shares) på Nasdaq-børsen i USA, og første handelsdag ventes å være 24. februar under ticker “IDBA”.

Det fremgår av en SEC-filing fredag 19. februar.

[holmes]

Godkjent utvikling her i dag

[BioMed]

Bell Ceremonies on Livestream

[TekBot]

Registration of new shares in IDEX Biometrics 23 February 2021

Reference is made to the private placement of about 83.2 million shares in IDEX
Biometrics ASA on 15 February 2021. The capital increase has been registered.
The company’s share capital is now NOK 137,304,213.30 divided into 915,361,422
…

Vis børsmeldingen

shares, each with a par value of NOK 0.15.

A listing prospectus will be prepared and published as soon as practical. About
29.4 million of the new shares have been issued to a separate, temporary ISIN
and that will be restricted from trading on Oslo Børs until after publication of
the prospectus.

For further information contact:

Marianne Bøe, Investor Relations
E-mail: [email protected]
(https://www.globenewswire.com/Tracker?data=oK5zwNtRsZ1s5umKWlj0gvhxK4PRPMGHg8q9
WpY79SVXH4zYq–0sgcQP_Odo0-K69jgeZX2OpVVepCuqIf4kSf6qGBkxSGU_Vjk3s4scM-PtiXZkVss
8JPP0gq8wLKP)
Tel: + 47 9180 0186

Derek D’Antilio, Chief Financial Officer
E-mail: [email protected]
(https://www.globenewswire.com/Tracker?data=NghbW6xavXLF5obCVfdzmc3LhTUlGrHuAht8
f2beuandwsSmDxOd7caa681Ap4HDzzQw6c8F_ZTqmE0ck6fO2aEGuTWuy8pP2wwWd_ZdJu66Ub6vEGkv
dYgF66yNOfZItrZaAyEQcTF4l3tFopZR8A==)
Tel: +1 978 273 1344

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
touch-free authentication for all. We help people make payments, prove their
identity, gain access to information, unlock devices or gain admittance to
buildings. We invent, engineer, and commercialize these secure and safe yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics.

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

IDEX Biometrics ADSs to be Listed on Nasdaq as of 1 March

Oslo, Norway, 24 February 2021: IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF)
(the “Company”), a leading provider of advanced fingerprint identification and
authentication solutions, today announced that the Company will list American
…

Vis børsmeldingen

Depositary Shares (“ADSs”) each representing 75 ordinary shares of the Company
(“Ordinary Shares”) on the Nasdaq Capital Market (“Nasdaq”). Nasdaq has approved
the ADSs for listing, and they are expected to begin trading under the symbol
“IDBA” on 1 March 2021, subject to approval by the U.S. Securities and Exchange
Commission (“SEC”).

A registration statement was filed with the SEC to facilitate the creation of a
trading market in the United States for ADSs. The Company has not registered any
new issuance of securities and is not making any public offering of new shares
or private placement of shares in connection with the listing on Nasdaq. The
Company’s Ordinary Shares will continue to be admitted to trading on the Oslo
Børs.

IDEX has prepared a series of frequently asked questions (“FAQs”) shown below
applicable to holders of the Ordinary Shares and to explain the optional process
of exchanging Ordinary Shares for ADSs if a shareholder so chooses. For any
further questions about the Ordinary Share to ADS exchange process, please
contact the Company’s ADS Depositary Bank, The Bank of New York Mellon at
[email protected] (mailto:[email protected]).

This announcement shall not constitute an offer to sell, or the solicitation of
an offer to buy, nor shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation, or sale would be unlawful prior
to registration or qualification under the securities laws of any such state or
jurisdiction. A registration statement relating to these securities has been
filed with the SEC but has not yet become effective. These securities may not be
sold nor may offers to buy be accepted prior to the time the registration
statement becomes effective. A prospectus describing the securities referenced
herein may be obtained, when available, from the website of the SEC at
http://www.sec.gov.

For further information contact:

Marianne Bøe, Investor Relations

E-mail: [email protected] (mailto:[email protected])
Tel: + 47 918 00186

Derek D’Antilio, Chief financial Officer

E-mail: [email protected]
(mailto:[email protected])
Tel: +1 978 273 1344

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com) and follow on Twitter @IDEXBiometrics

Forward-Looking Statements

Certain statements made in this announcement are forward-looking statements
including with respect to the effectiveness of the registration filed with the
SEC, the anticipated listing date of the ADSs on Nasdaq and the creation of a
trading market for the ADSs in the United States. These forward-looking
statements are not historical facts but rather are based on the Company’s
current expectations, estimates, and projections about its industry; its
beliefs; and assumptions. Words such as ‘anticipates,’ ‘expects,’ ‘intends,’
‘plans,’ ‘believes,’ ‘seeks,’ ‘estimates,’ and similar expressions are intended
to identify forward-looking statements. These statements are not guarantees of
future performance and are subject to known and unknown risks, uncertainties,
and other factors, some of which are beyond the Company’s control, are difficult
to predict, and could cause actual results to differ materially from those
expressed or forecasted in the forward-looking statements. The Company cautions
securityholders and prospective securityholders not to place undue reliance on
these forward-looking statements, which reflect the view of the Company only as
of the date of this announcement. The forward-looking statements made in this
announcement relate only to events as of the date on which the statements are
made. The Company will not undertake any obligation to release publicly any
revisions or updates to these forward-looking statements to reflect events,
circumstances, or unanticipated events occurring after the date of this
announcement except as required by law or by any appropriate regulatory
authority.

Frequently Asked Questions and Answers for IDEX Ordinary Shareholders:

Which stock exchanges is IDEX listed on?
ADSs representing IDEX’s Ordinary Shares are expected to be listed on Nasdaq
under the ticker symbol “IDBA”, and IDEX’s Ordinary Shares are listed on the
Oslo Børs, a market operated by the Oslo Stock Exchange, under the symbol
“IDEX.”

Why have a dual listing of IDEX’s shares?
The dual listing on Nasdaq and OSE makes IDEX’s shares more accessible to U.S.
institutional and retail investors while also remaining listed on the OSE.

What is the relationship between the Company’s Ordinary Shares and ADSs?
Each ADS will be a tradeable security representing 75 of the Company’s Ordinary
Shares. The value of each ADS is denominated in U.S. Dollars.

How do I exchange my Ordinary Shares into ADSs?
The process set out in the following explains what you need to do to select a
suitable broker account and summarizes the instructions that you need to give to
your broker in order to exchange your Ordinary Shares into ADSs. Please refer to
“Notes for Brokers” which we suggest you send to your broker if you are
interested in exchanging Ordinary Shares for ADSs.

Do I have to exchange my Ordinary Shares into ADSs?
No, the Company’s Ordinary Shares will continue to trade on the Oslo Børs market
of the OSE. If you do not wish to hold ADSs but wish to remain a holder of
IDEX’s Ordinary Shares then no action is required.

Are all Ordinary Shares eligible to be deposited for delivery of ADSs?
No. Ordinary Shares that are owned by an executive officer or director or other
person that may be considered an “affiliate” of the Company under U.S.
securities law and Ordinary Shares that were received in a private placement and
have been held for less than a year are generally not eligible to be deposited.
If your Ordinary Shares fall into one of these categories, please contact
[email protected] (mailto:[email protected]) for
more information on whether you will be allowed to deposit and under what
conditions.

What does it cost to exchange Ordinary Shares into ADSs?
There will be an issuance fee of up to US$5.00 per 100 ADSs (or portion thereof)
charged by The Bank of New York Mellon for the issuance of the ADSs. The
exchange of your dematerialized Ordinary Shares will need to be managed by your
broker as Ordinary Shares need to be transferred electronically to The Bank of
New York Mellon prior to the issuance of ADSs. Your selected broker may also
levy an administrative charge for managing the exchange process.

I don’t have a broker - do I really need one?
Yes, exchange into ADSs will require the assistance of a U.S. registered broker.
Please refer to “Notes for Shareholders”.

Is there a cost to hold ADSs?
The Bank of New York Mellon may charge an annual Depositary Service Fee of up to
US$0.05 per ADS. This is typically collected from the broker or other
intermediary that holds the ADSs on your behalf. Your broker may pass this fee
on to you directly or it may be part of the annual fee that you pay to maintain
your brokerage account.

Notes for Shareholders:

Process for exchanging Ordinary Shares into ADSs:

Step 1: Select a broker with U.S. listed securities trading capability. You need
to ensure that the broker and type of account on offer is capable of holding and
trading U.S. listed securities. Often the most basic account offered is for
Norwegian listed shares only so you will need to select an account that gives
you the ability to buy and sell U.S. listed shares. Please ensure that you check
with your broker that they can hold IDEX Biometrics ASA ADSs and have a DTC
participant account.

Step 2: You will need to contact your broker and ask them how to transfer your
existing Ordinary Shares into your U.S. account.

Step 3: Your broker will need to contact The Bank of New York Mellon by email to
arrange for the exchange of your Ordinary Shares into ADSs tradeable on Nasdaq.
You will receive one ADS for every 75 Ordinary Shares that you hold and opt to
deposit.
The contact details for The Bank of New York Mellon, together with details of
the conversion process are outlined in the “Notes for Brokers” below. We suggest
that you send this to your broker.

Notes for Brokers:

Conversion of Ordinary Shares into ADSs tradeable on Nasdaq

Ordinary Shares are traded on Oslo Børs under the ticker: IDEX.

IDEX Biometric ADSs are expected to be listed and traded on Nasdaq under the
ticker: IDBA.
Each ADS will represent 75 Ordinary Shares.
Ordinary Shares can be exchanged into the equivalent number of ADSs via the
Company’s Depositary Bank, The Bank of New York Mellon.

Once exchanged, the ADSs will be tradeable via Nasdaq.

Ordinary Shares to be deposited for delivery of ADSs must be transferred
electronically to Nordea Bank AB (Publ), filial i Norge, as custodian, with
instructions to credit the account of The Bank of New York Mellon and notify the
Depositary Bank of the deposit.

Instructions must be given identifying a broker or other securities intermediary
that is a participant in The Depository Trust company (DTC) to receive credit of
the ADSs issuable in respect of the deposit and providing any further credit
information required by the DTC participant.

The ADS issuance fee of US$5.00 per 100 ADSs (or portion thereof) must be paid
to the Depositary Bank.

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[Smb]

2,75 NOK per aksje i emisjonen var ikkje so dårleg. Tar eit bet her for å sjå korleis mottakelsen blir i USA.

[TekBot]

Grant of incentive subscription rights in IDEX Biometrics 24 February 2021

The board of directors of IDEX Biometrics ASA resolved on 24 February 2021 to
issue 934,900 incentive subscription rights to employees in the IDEX group. The
grant was made under the company’s 2020 incentive subscription rights plan as
…

Vis børsmeldingen

resolved at the annual general meeting on 15 May 2020. The exercise price of the
subscription rights is NOK 3.10 per share. The subscription rights vest by 25%
per year over four years and expire on 15 May 2025. Following the grant there
are 57,278,993 subscription rights outstanding in IDEX.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: [email protected]
Tel: + 47 9180 0186

Derek D’Antilio, Chief Financial Officer
E-mail: [email protected]
Tel: +1 978 273 1344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[TekBot]

IDEX Biometrics - Interim report for the fourth quarter and preliminary result of 2020

The report and an updated company presentation are enclosed in pdf files.

Fourth Quarter and Preliminary Full Year Financial Results
…

Vis børsmeldingen

o Fourth quarter 2020 revenue was $598 thousand compared to $71
thousand in the fourth quarter 2019 as revenue begins to accelerate
o Full year 2020 revenue was $1.1 million, including $1 million in
product revenue, compared to $159 thousand in product revenue in 2019
o Fourth quarter and full year gross margins(*) were 70% and 75%,
respectively
o 2020 Adjusted Operating Expenses(**) were $21.4 million, a decrease
of $4.9 million or 19% compared to $26.3 million in 2019
o Net loss narrowed to $26.8 million in 2020 from $32.4 million in
2019
o Ended the year with $7.3 million in cash and raised $26.1 million,
net of fees, in a private placement on February 15, 2021
o IDEX was approved to list on the Nasdaq and expects to begin
trading on March 1, 2021 under ticker IDBA

Commercial and Market Updates
o After securing an initial order in the third quarter, IDEX received
an additional production order for TrustedBio™ sensors from a tier 1 card
manufacturer in late 2020 that will be incorporated in a card available to
financial institutions early 2021
o Achieved an additional China UnionPay (CUP) certification for dual
interface biometric payment cards with its partner Goldpac. This is the second
certification with a card manufacturer on the CUP network
o IDEX’s sensor was featured by our partner, CTD, in the first trial
of a fingerprint card for a digital RMB hardware wallet in a trial by Postal
Savings Bank of China. The DCEP digital currency initiative in China represents
a large market opportunity beyond the traditional payment card market.
o Continued to expand its strategic partnerships and added a third
global payment network to deliver its fingerprint sensors and related biometric
solutions
o Received advanced volume production orders of TrustedBio sensors
from multiple tier 1 card manufacturers to secure allocation of future supply
o Expanded its direct customer engagements with tier 1 innovation
leaders, representing over 40% share of the global payment card market
o Continued to ramp production shipments to a large IT and financial
services customer for an information security access control solution

Vince Graziani, CEO of IDEX, commented: “During 2020 we made good progress
transitioning from pure product development to commercial activities and ramping
of deliveries. Throughout the year we achieved several certifications by
multiple major payment networks. Several new card manufacturers have initiated
new product developments based on IDEX’s biometric technologies. In addition to
ramping commercial production shipments for a large IT and financial services
customer, we successfully secured the first commercial orders and began shipment
of our next-generation TrustedBio™ solution for biometric payment cards.”

He added: “Entering the new year, the Postal Savings Bank of China announced the
first trial of a fingerprint biometric card hardware-wallet as part of China’s
digital renminbi (RMB) initiative. This initiative represents a new high-
volume application for fingerprint biometrics. We expect 2021 will see broader
use of our technology for these new digital currency applications globally, and
increasing orders and shipments to a broader range of traditional customers,
banks and credit issuers.”

Notes:

• Gross Margin is Total Revenue less Purchases, net of inventory change
  ** Adjusted Operating Expense is Total Operating Expenses less stock
  compensation expense, amortization and depreciation expense, and expense related
  to the Nasdaq listing

For further information contact:
Marianne Bøe, Investor Relations
E-mail: [email protected]
Tel: + 47 9180 0186

Derek D’Antilio, Chief Financial Officer
E-mail: [email protected]
Tel: +1 978 273 1344

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of
fingerprint identification technologies offering simple, secure and personal
authentication for all. We help people make payments, prove their identity,
gain access to information, unlock devices or gain admittance to buildings with
the touch of a finger. We invent, engineer, and commercialize these secure, yet
incredibly user-friendly solutions. Our total addressable market represents a
fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow on Twitter
@IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

Kilde

[Autolock]

Hvordan fungerer noteringen på nasdaq? Blir det dobbelt så mange aksjer?

[Ebitor]

Er skremt av det vanvittige antallet tegningsretter ledelsen har tildelt, som fortsatt ikke er utløpt på dato.

The board of directors of IDEX Biometrics ASA resolved on 24 February 2021 to
issue 934,900 incentive subscription rights to employees in the IDEX group. The
grant was made under the company’s 2020 incentive subscription rights plan
resolved at the annual general meeting on 15 May 2020. The exercise price of the
subscription rights is NOK 3.10 per share. The subscription rights vest by 25%
per year over four years and expire on 15 May 2025. Following the grant there
are 57,278,993 subscription rights outstanding in IDEX.

[NidarosEsp1]

The Company has not registered any
new issuance of securities and is not making any public offering of new shares
or private placement of shares in connection with the listing on Nasdaq. The
Company’s Ordinary Shares will continue to be admitted to trading on the Oslo
Børs.

[Eventyr.No]

Skjønner ikkje korleis dei kan handle aksjer da når åpningstider er forskjellige og dei ikkje har sine egne aksjer. Eller misforstår eg?
.